SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Board Changes

10 Dec 2019 07:00

RNS Number : 2749W
Forterra plc
10 December 2019
 

10 December 2019

 

Forterra plc

Board Changes

 

Forterra plc ("Forterra" or the "Company") announces that Shatish Dasani is stepping down from his role as Chief Financial Officer and as a Director of the Board on 31 December 2019 to pursue other opportunities. Forterra also announces that Ben Guyatt will be appointed as Chief Financial Officer on 1 January 2020 and will join the Board of Forterra at that point.

 

Shatish Dasani joined Forterra in December 2015 and was a key member of the leadership team which successfully took the Company through the IPO in April 2016 and implemented the strategy to drive value for shareholders. In his time with Forterra, he has overseen a significant deleveraging and strengthening of its balance sheet, whilst investing in the core businesses and following a progressive dividend policy.

 

Ben Guyatt has served as Director of Finance and Company Secretary of Forterra since its listing in April 2016 and, prior to this, he was Finance Director of the business at the time of its divestment by HeidelbergCement in 2015. Ben joined Hanson plc in 2006 and held a variety of senior finance and strategy roles within Hanson and HeidelbergCement. Previously Ben held financial management roles at Heath Lambert. The Board believes that Ben will bring a deep and valuable knowledge of Forterra, and the wider market, to the Board.

 

Justin Atkinson, Chairman, commented:

 

"On behalf of the Board I would like to thank Shatish for his substantial contribution to the Company over the last four years and wish him well in the next stage of his career.

 

"I am delighted that Ben will be joining the Board as Chief Financial Officer. Having worked with Ben since the successful IPO, I am convinced he will bring significant knowledge and experience to the Board."

 

Shatish Dasani commented:

 

"I have enjoyed tremendously my time at Forterra and would like to thank the Board and all members of staff for their support. I leave the Group in a strong financial and strategic position, with great potential to continue delivering value for all stakeholders. After four years with the Group, I believe that this is the right time for me to pursue other career opportunities. I wish the team well as they take the business on the next stage of its development."

 

 

Enquiries

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

 

 

The Company confirms that there are no other disclosures to be made in connection with Ben Guyatt's appointment under LR 9.6.13R of the Listing Rules.

 

Shatish Dasani's leaving arrangements have been determined in accordance with our Directors' Remuneration Policy. The statement required by s.430 (2B) of the Companies Act 2006 will be made available for shareholders on the Company's website as soon as reasonably practicable following the date on which Mr Dasani ceases to be a Director.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAVKLFBKLFEFBX
Date   Source Headline
21st Sep 20218:11 amRNSHolding(s) in Company
17th Sep 202111:21 amRNSDirector Declaration
3rd Sep 20213:22 pmRNSEmployee Benefit Trust Share Purchase
27th Aug 20212:58 pmRNSDirector/PDMR Shareholding
27th Aug 202111:15 amRNSDirector Declaration
26th Aug 20217:00 amRNSDisposal of Swadlincote site
9th Aug 20219:32 amRNSHolding(s) in Company
3rd Aug 20212:49 pmRNSEmployee Benefit Trust Share Purchase
29th Jul 20217:56 amRNSProgressive publishes new research
29th Jul 20217:00 amRNSHalf-year Report
13th Jul 20216:03 pmRNSDirector/PDMR Shareholding
5th Jul 202111:22 amRNSEmployee Benefit Trust Share Purchase
15th Jun 20219:56 amRNSDirector/PDMR Shareholding
7th Jun 20219:24 amRNSEmployee Benefit Trust Share Purchase
27th May 20213:45 pmRNSDirector/PDMR Shareholding
18th May 20213:45 pmRNSAnnual General Meeting 2021 Results
18th May 202110:28 amRNSProgressive publishes new research
18th May 20217:00 amRNSTrading Statement
6th May 20217:00 amRNSEmployee Benefit Trust Share Purchase
30th Apr 20214:07 pmRNSHolding(s) in Company
30th Apr 20211:11 pmRNSGrant under Performance Share Plan
9th Apr 20213:46 pmRNSDirector/PDMR Shareholding
9th Apr 202110:56 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSAnnual Report 2020 and Notice of AGM 2021
8th Apr 20213:31 pmRNSEmployee Benefit Trust Share Purchase
1st Apr 202110:59 amRNSDirector/PDMR Shareholding
30th Mar 20211:14 pmRNSDirector/PDMR Shareholding
25th Mar 20212:41 pmRNSDirector/PDMR Shareholding
22nd Mar 20213:55 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNS2020 FULL YEAR RESULTS
4th Mar 20217:24 amRNSHolding(s) in Company
3rd Mar 202110:36 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSEmployee Benefit Trust Share Purchase
17th Feb 20213:16 pmRNSHolding(s) in Company
15th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20212:16 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:17 pmRNSEmployee Benefit Trust Share Purchase
1st Feb 20214:48 pmRNSDirector/PDMR Shareholding
28th Jan 202112:38 pmRNSHolding(s) in Company
27th Jan 20213:40 pmRNSHolding(s) in Company
26th Jan 20218:15 amRNSProgressive publishes new research
26th Jan 20217:00 amRNSTrading Statement
6th Jan 20217:21 amRNSEmployee Benefit Trust Share Purchase
6th Jan 20217:21 amRNSDirector/PDMR Shareholding
4th Jan 20219:29 amRNSHolding(s) in Company
8th Dec 20202:28 pmRNSEmployee Benefit Trust Share Purchase
27th Nov 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20201:00 pmRNSEmployee Benefit Trust Share Purchase
24th Nov 20208:24 amRNSProgressive publishes new research

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.